# Albuterol HFA MDI in Pediatric Participants With Asthma

> **NCT00577655** · PHASE3 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 103 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Albuterol
- **DRUG:** Placebo
- **DRUG:** Proventil® HFA

## Key facts

- **NCT ID:** NCT00577655
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577655, "Albuterol HFA MDI in Pediatric Participants With Asthma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00577655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*